DENNIS HAFFORD: Open Payments
NPI 1134357338 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 26 payments from 12 companies in 2025. Trend: 2023 $511 · 2024 $384 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 3 | $87 |
| TOLMAR, INC. | 5 | $77 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Procept Biorobotics Corporation | 2 | $72 |
| Janssen Biotech, Inc. | 4 | $71 |
| Boston Scientific Corporation | 3 | $66 |
| UROGEN PHARMA, INC. | 1 | $25 |
| Verity Pharmaceuticals Inc. | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: ADSTILADRIN, AQUABEAM ROBOTIC SYSTEM, ERLEADA, ORGOVYX, JATENZO, LithoVue, ELIGARD, Moses.
Industry payments across MO — which companies pay providers there.
